DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

BePharbel Manufacturing

www.bepharbel.com/en/controlled-release-systems/Courcelles, Belgium
12 profile visits

About

Bepharbel is a pharmaceutical CDMO specialized in liquid oral dosage forms. In parallel, the company has developed MMCR™, a proprietary liquid formulation platform technology enabling gastro‑resistant and prolonged release, and is now expanding this platform into veterinary development.

Areas of Activity

Pharma

Representatives

Borg Hemelaer

Business Development Officer

BePharbel Manufacturing

Marketplace (1)

  • Project cooperation

    MMCR formulation platform - co-development, licensing & investment.

    MMCR™ is a proprietary technology enabling gastro‑resistant and prolonged‑release properties in liquid formulations. Following human development, we aim to expand MMCR™ into companion animals and horses via co‑development and licensing.

    • Animal Health
    • Licensing Partner
    • Investment Partner
    • Distribution Partner
    • Research Collaboration
    • Commercialisation Partner
    • TRL 5: Technology validation in relevant environment
    Author

    Borg Hemelaer

    Business Development Officer at BePharbel Manufacturing

    Courcelles, Belgium